GT1b functions as a novel endogenous agonist of toll‐like receptor 2 inducing neuropathic pain

Published: 2020-02-06

DOI: 10.15252/embj.2019102214

Affiliations: 8

Authors: 13

Institutions	Authors	Share
College of Medicine (CM), SNU, South Korea		0.15
Dental Research Institute (DRI), SNU, South Korea		0.15
Department of Chemistry, SNU, South Korea		0.15
Department of Applied Chemistry, KHU, South Korea		0.15
College of Natural Science, DKU, South Korea		0.15
Ajou University School of Medicine (AUSOM), South Korea		0.08
College of Medical Engineering, Konyang University, South Korea		0.08
Department of Pharmacology and Molecular Sciences, JHU, United States of America (USA)		0.08

Return

Latest supplement

Nature Index 2020 South Korea

A concerted government push to make South Korea an innovation leader, backed by strong investment and systemic reform, has brought rapid and long-lasting results. The country’s scientific landscape is becoming more diverse and more productive, as a place where upwardly mobile researchers thrive.

Access free